Market closedNon-fractional

AADi Bioscience/AADI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About AADi Bioscience

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Ticker

AADI

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Pacific Palisades, United States

Employees

75

AADi Bioscience Metrics

BasicAdvanced
$33M
Market cap
-
P/E ratio
-$2.55
EPS
0.35
Beta
-
Dividend rate
$33M
0.35
5.161
4.69
0.816
1.286
-323.03%
-33.11%
-58.22%
1.503
0.35
0.35
-0.584
26.97%
-0.94%
17.78%
-22.21%

What the Analysts think about AADi Bioscience

Analyst Ratings

Majority rating from 5 analysts.
Buy

AADi Bioscience Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-343.39% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$5.3M
-15.87%
Net income
-$18M
12.35%
Profit margin
-343.39%
33.54%

AADi Bioscience Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 5.84%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.67
-$0.60
-$0.60
-$0.68
-
Expected
-$0.62
-$0.72
-$0.65
-$0.64
-$0.69
Surprise
7.72%
-17.13%
-7.41%
5.84%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for AADi Bioscience stock?

AADi Bioscience (AADI) has a market cap of $33M as of July 06, 2024.

What is the P/E ratio for AADi Bioscience stock?

The price to earnings (P/E) ratio for AADi Bioscience (AADI) stock is 0 as of July 06, 2024.

Does AADi Bioscience stock pay dividends?

No, AADi Bioscience (AADI) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next AADi Bioscience dividend payment date?

AADi Bioscience (AADI) stock does not pay dividends to its shareholders.

What is the beta indicator for AADi Bioscience?

AADi Bioscience (AADI) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell AADi Bioscience stock

Buy or sell AADi Bioscience stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing